Loading patent…
AssigneeGroupe Santé Devonian Inc.
InventorsAndré P. Boulet, Theophilus J. Gana, Nathalie Boucher
Estimating the term…
There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of cardiovascular diseases, and method for the treatment thereof. The cardiovascular diseases (CVD) may comprise several diseases associated with inflammation of the heart or arteries and include coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack), atherosclerosis, stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis.
-39. (canceled)
A method for treating cardiovascular diseases (CVD) in a subject in need thereof, comprising administering to said subject an effective amount of a thylakoid extract comprising purified functional photosynthetic pigments in their thylakoid membrane environment, particularly in admixture with a physiologically acceptable carrier.
-57. (canceled)
A method for decreasing a baseline level of blood CRP or blood hsCRP in a subject in need thereof, comprising administering to said subject an effective amount of a thylakoid extract comprising purified functional photosynthetic pigments in their thylakoid membrane environment, wherein said baseline level of CRP or hsCRP prior to administration of the composition is indicative of chronic inflammation, and said effective amount comprises decreased said baseline level by least about 25% after 14 days.
Dependencies are inferred from the claim text.